Company

In collaboration with our business partners, we facilitate the process of developing, manufacturing, testing, registering, selling, and delivering the generic small-molecule drugs and biotechnologies for which we hold intellectual property. Here are the steps:

Prior to Development
Step 0:
Name-brand Drug Creation
Innovator pharmaceutical companies develop name-brand (originator) drugs
Pre-Production
Step 1:
Product Development
Generics contract research organizations (CROs) perform research & development to identify and process originator drugs’ active pharmaceutical ingredients (API)
Step 2:
Product Acquisition
Boston Oncology acquires seed material of APIs from CROs, along with rights to use APIs within license regions, to create a world-class portfolio of treatments
Step 3:
Equipment & Supply Acquisition
Boston Oncology acquires the designs and equipment from pharmaceutical input suppliers to process APIs and produce final drugs
Step 4:
Local Investment
Boston Oncology joins with local partners to construct factories in developing nations and emerging markets to produce the drugs
Production
Step 5:
CMO Production
While factory construction is underway, contract manufacturing organizations (CMOs) produce drugs in their own facilities so Boston Oncology can begin clinical trials and registration
Step 6:
Clinical Trials &
Product Registration
Boston Oncology begins clinical trials to register drugs in host country
Step 7:
Local Production
Once factories are complete and drug registration is secured, CMOs hand off production to factories
Step 8:
Factory Validation
Regulators validate that Boston Oncology’s factories can produce drugs of the same quality as the drugs produced by the CMOs
Step 9:
Local Sales
Boston Oncology begin selling drugs to physicians, hospital administrators, and government health agencies and/or payers
Post-Production
Step 10:
Ongoing Relationships
Boston Oncology maintains a pipeline of future products from CROs and quality assurance and maintenance support from CMOs; ensures global factories continuously communicate and implement best practices